Rachel K. King
2016
In 2016, Rachel K. King earned a total compensation of $1.2M as President and Chief Executive Officer at GlycoMimetics, a 10% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $280,543 |
---|---|
Option Awards | $461,070 |
Salary | $487,900 |
Other | $3,975 |
Total | $1,233,488 |
King received $487.9K in salary, accounting for 40% of the total pay in 2016.
King also received $280.5K in non-equity incentive plan, $461.1K in option awards and $4K in other compensation.
Rankings
In 2016, Rachel K. King's compensation ranked 7,247th out of 14,075 executives tracked by ExecPay. In other words, King earned more than 48.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,247 out of 14,075 | 49th |
Division Manufacturing | 2,729 out of 5,489 | 50th |
Major group Chemicals And Allied Products | 895 out of 1,895 | 53rd |
Industry group Drugs | 695 out of 1,538 | 55th |
Industry Pharmaceutical Preparations | 553 out of 1,176 | 53rd |
Source: SEC filing on April 20, 2017.
King's colleagues
We found three more compensation records of executives who worked with Rachel K. King at GlycoMimetics in 2016.